On June 28, 2023, JanOne made a significant move by filing an international patent application for innovative methods involving the utilization of low dose naltrexone to effectively address chronic pain. This groundbreaking development showcases JanOne’s dedication to finding novel solutions for complex regional pain syndrome (CRPS), an orphan disease that currently lacks FDA-approved treatments.
Low-dose naltrexone (LDN) has emerged as a prominent treatment option for various conditions such as fibromyalgia, CRPS, and painful diabetic neuropathy. The potential of LDN extends beyond chronic pain, as studies have indicated its promise in mitigating autoimmune disorders and even combating certain cancers. However, further research is required to fully ascertain its efficacy in treating these conditions.
It is worth noting that JanOne has already obtained a U.S. patent for their revolutionary method of enhancing nerve function using JAN101, which may also contribute to alleviating pain. This patent demonstrates JanOne’s commitment to advancing medical breakthroughs and improving the lives of individuals suffering from debilitating pain.
Updated on: 26/02/2024
Debt to equity ratio: Strong Sell
Price to earnings ratio: Strong Sell
Price to book ratio: Neutral
DCF: Strong Buy
ROE: Strong Sell
We did not find social sentiment data for this stock
There are no analysts data to display
JAN Stock Performance on June 28, 2023: Mixed Results with Potential Undervaluation
JAN Stock Performance on June 28, 2023
On June 28, 2023, JAN stock had a mixed performance, with a slight increase in price but a decrease in trading volume.
Starting with the previous day’s closing price of $0.98, JAN stock opened at $0.99 on June 28. Throughout the day, the stock’s price fluctuated between a low of $0.99 and a high of $1.06.
The trading volume for the day was 17,064 shares. This is significantly lower than the average volume of 272,147 shares over the past three months.
JAN’s market capitalization stands at $3.7 million, indicating that it is a small-cap stock.
The price-to-earnings (P/E) ratio for JAN stock is 0.9, which is relatively low. Additionally, the price-to-sales ratio is 0.11, indicating that the stock is trading at a low multiple of its sales. The price-to-book ratio is 1.38, suggesting that the stock is trading at a slight premium to its book value.
Looking at the stock’s performance on June 28, three other companies in the same industry are listed. USRI and NTURN had no change in their stock prices, while QRHC saw a positive change of $0.15 or 2.50%. SCHN, on the other hand, experienced a decrease of $1.00 or 3.15% in its stock price.
JAN is part of the Industrial Services sector and operates in the Environmental Services industry. The company is headquartered in Las Vegas, Nevada.
In conclusion, JAN stock had a mixed performance on June 28, 2023, with a slight increase in price but a decrease in trading volume. The stock’s financial indicators, such as the low P/E ratio and price-to-sales ratio, suggest that it might be undervalued. However, the decline in revenue growth in the last year is a concern. Investors should carefully analyze the company’s future prospects and financial health before making any investment decisions.
Janone Incs Stock Performance on June 28, 2023: Analysts Forecast Significant Increase and Consensus Hold Rating
On June 28, 2023, Janone Inc’s stock performance caught the attention of investors and analysts alike. According to data sourced from CNN Money, one analyst offered a 12-month price forecast for Janone Inc with a median target of $20.00. The high estimate and low estimate were also reported to be $20.00, indicating a consensus among analysts. The consensus among the polled investment analysts is to hold stock in Janone Inc. This rating has remained steady since November and has not changed from a hold rating. The significant increase projected by analysts for Janone Inc’s stock price suggests that there may be positive developments on the horizon for the company. As of now, specific details regarding the current quarter’s earnings per share and sales for Janone Inc are not available. The reporting date for these figures is yet to be determined (TBD). In conclusion, the stock performance of Janone Inc on June 28, 2023, has garnered attention due to the optimistic price forecast provided by analysts. With a median target of $20.00, representing a 1,841.75% increase from the last recorded price, investors may be intrigued by the potential for significant returns. However, it is important to approach investing with caution and consider all available information before making any decisions.